about
Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.PD-L1 Expression and CD8(+) T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer.Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.Probing instructions for expression regulation in gene nucleotide compositions.Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies.Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancerQuantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision MedicineThe clinical role of the TME in solid cancerComprehensive evaluation of computational cell-type quantification methods for immuno-oncologyC5 nephritic factors drive the biological phenotype of C3 glomerulopathiesImmune-based identification of cancer patients at high risk of progressionComprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncologyGuadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical TrialRecovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimenUse of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic SyndromeToll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cellsContext-dependent roles of complement in cancerIntra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinomaEarly hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive moleculesTertiary lymphoid structures in the era of cancer immunotherapyRevisiting immune escape in colorectal cancer in the era of immunotherapyImpact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndromeTumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor GrowthB cells and tertiary lymphoid structures promote immunotherapy responseB cells are associated with survival and immunotherapy response in sarcoma
P50
Q36244981-C5EA8DA2-6A46-400E-84BC-B78BF62B3E40Q37356734-9ED51B4A-8EA8-4EA3-9181-0755C2FF4A2BQ38954619-1209A67F-B814-4388-97F7-E57B7A63D5F4Q40115458-5AC2F8E9-3B4B-43F5-B240-5F6851BE9B5BQ42359785-4CD61886-2C87-475B-B247-826111474174Q47224226-758970C3-4B2B-4832-9774-74C058E5E0EBQ47959293-92801A77-B7BC-4B9C-9FDA-77F8E2150360Q57470561-344B0208-D01A-46D8-A22C-C633ADDC140FQ57492123-2ACDFCC1-83D2-43D2-98B6-F343A8926394Q58561576-6D1A4F2E-D52E-437E-BBB9-B655ED048C94Q62779842-4D3A0990-83FC-42D0-A193-B16D73F9ACB0Q63564990-85764725-1B4E-4495-832F-F460EDBA8913Q88098364-6D5F6702-6236-4D73-B247-2C5704CF778FQ90064857-E99FA0A5-C53E-49A3-9433-4D801D284524Q90148371-5D1B6F8B-9F84-4C19-BB3B-4C86306B7F51Q90149778-085BD7DC-FA93-48CE-AE90-BBB1A090D12EQ90424340-BEA39671-D6D9-46B7-B4B0-31F2DF831BCDQ90468281-202309F0-1E1C-494C-B0C9-0CAA6F014CCBQ91013849-530DB300-4621-4CC2-A00B-702FF6E60B8BQ91433947-603450E4-1D95-45CE-90E8-061014AF22F4Q91737497-1D55C757-4D80-403E-9869-CB5C63BC2B4BQ92052710-3C2A4E77-CD19-4387-A561-29D17BC72D29Q92311646-3B0D328C-4EFE-4EC2-8076-B788DAB0C12DQ92487694-7A8FF586-6654-420D-B86E-DFC976BF8C80Q92523621-6BF00979-4FB4-49D5-AC3A-86AC27E70E22Q92669559-726AF6C3-6D7E-42FB-8DDE-D1C80CE8730EQ92669566-0307BCF4-6341-40F8-B154-CDE5AE61B5C6
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Florent Petitprez
@ast
Florent Petitprez
@en
Florent Petitprez
@es
Florent Petitprez
@nl
type
label
Florent Petitprez
@ast
Florent Petitprez
@en
Florent Petitprez
@es
Florent Petitprez
@nl
prefLabel
Florent Petitprez
@ast
Florent Petitprez
@en
Florent Petitprez
@es
Florent Petitprez
@nl
P106
P31
P496
0000-0002-5117-6466